BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36190479)

  • 1. Prader-Willi syndrome, deletion subtypes, and magnesium: Potential impact on clinical findings.
    Butler MG; Cowen N; Bhatnagar A
    Am J Med Genet A; 2022 Nov; 188(11):3278-3286. PubMed ID: 36190479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prader-Willi Syndrome and Chromosome 15q11.2 BP1-BP2 Region: A Review.
    Butler MG
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of 4 genes between chromosome 15 breakpoints 1 and 2 and behavioral outcomes in Prader-Willi syndrome.
    Bittel DC; Kibiryeva N; Butler MG
    Pediatrics; 2006 Oct; 118(4):e1276-83. PubMed ID: 16982806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic analysis of the chromosome 15q11-q13 Prader-Willi syndrome region and characterization of transcripts for GOLGA8E and WHCD1L1 from the proximal breakpoint region.
    Jiang YH; Wauki K; Liu Q; Bressler J; Pan Y; Kashork CD; Shaffer LG; Beaudet AL
    BMC Genomics; 2008 Jan; 9():50. PubMed ID: 18226259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnesium Supplement and the 15q11.2 BP1-BP2 Microdeletion (Burnside-Butler) Syndrome: A Potential Treatment?
    Butler MG
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31207912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prader-Willi syndrome and atypical submicroscopic 15q11-q13 deletions with or without imprinting defects.
    Hassan M; Butler MG
    Eur J Med Genet; 2016 Nov; 59(11):584-589. PubMed ID: 27659713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Array comparative genomic hybridization (aCGH) analysis in Prader-Willi syndrome.
    Butler MG; Fischer W; Kibiryeva N; Bittel DC
    Am J Med Genet A; 2008 Apr; 146A(7):854-60. PubMed ID: 18266248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal Microarray Study in Prader-Willi Syndrome.
    Butler MG; Hossain WA; Cowen N; Bhatnagar A
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and genetic aspects of the 15q11.2 BP1-BP2 microdeletion disorder.
    Butler MG
    J Intellect Disabil Res; 2017 Jun; 61(6):568-579. PubMed ID: 28387067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of a novel familial deletion of four genes between BP1 and BP2 of the Prader-Willi/Angelman syndrome critical region by oligo-array CGH in a child with neurological disorder and speech impairment.
    Murthy SK; Nygren AO; El Shakankiry HM; Schouten JP; Al Khayat AI; Ridha A; Al Ali MT
    Cytogenet Genome Res; 2007; 116(1-2):135-40. PubMed ID: 17268193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria.
    Gunay-Aygun M; Schwartz S; Heeger S; O'Riordan MA; Cassidy SB
    Pediatrics; 2001 Nov; 108(5):E92. PubMed ID: 11694676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of four highly conserved genes between breakpoint hotspots BP1 and BP2 of the Prader-Willi/Angelman syndromes deletion region that have undergone evolutionary transposition mediated by flanking duplicons.
    Chai JH; Locke DP; Greally JM; Knoll JH; Ohta T; Dunai J; Yavor A; Eichler EE; Nicholls RD
    Am J Hum Genet; 2003 Oct; 73(4):898-925. PubMed ID: 14508708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three siblings with Prader-Willi syndrome caused by imprinting center microdeletions and review.
    Hartin SN; Hossain WA; Weisensel N; Butler MG
    Am J Med Genet A; 2018 Apr; 176(4):886-895. PubMed ID: 29437285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newborn screening for Prader-Willi syndrome is feasible: Early diagnosis for better outcomes.
    Mahmoud R; Singh P; Weiss L; Lakatos A; Oakes M; Hossain W; Butler MG; Kimonis V
    Am J Med Genet A; 2019 Jan; 179(1):29-36. PubMed ID: 30556641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of genetic subtypes of Prader-Willi syndrome with growth hormone therapy on intelligence and body mass index.
    Butler MG; Matthews NA; Patel N; Surampalli A; Gold JA; Khare M; Thompson T; Cassidy SB; Kimonis VE
    Am J Med Genet A; 2019 Sep; 179(9):1826-1835. PubMed ID: 31313492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 15q11.2 BP1-BP2 Microdeletion (
    Rafi SK; Butler MG
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32384786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo interstitial duplication of 15q11.2-q13.1 with complex maternal uniparental trisomy for the 15q11-q13 region in a patient with Prader-Willi syndrome.
    Burrage LC; Person RE; Flores A; Villanos MT; Bi W; Wiszniewska J; Bacino CA
    Am J Med Genet A; 2012 Oct; 158A(10):2557-63. PubMed ID: 22903639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique and atypical deletions in Prader-Willi syndrome reveal distinct phenotypes.
    Kim SJ; Miller JL; Kuipers PJ; German JR; Beaudet AL; Sahoo T; Driscoll DJ
    Eur J Hum Genet; 2012 Mar; 20(3):283-90. PubMed ID: 22045295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation-specific multiplex ligation-dependent probe amplification and identification of deletion genetic subtypes in Prader-Willi syndrome.
    Henkhaus RS; Kim SJ; Kimonis VE; Gold JA; Dykens EM; Driscoll DJ; Butler MG
    Genet Test Mol Biomarkers; 2012 Mar; 16(3):178-86. PubMed ID: 21977908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of induced pluripotent stem cells (KSCBi009-A) from a patient with Prader-Willi syndrome (PWS) featuring deletion of the paternal chromosome region 15q11.2-q13.
    Kim BY; Lee JS; Kim YO; Koo SK; Park MH
    Stem Cell Res; 2020 Jul; 46():101847. PubMed ID: 32474395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.